{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T22:48:05Z","timestamp":1788648485827,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T00:00:00Z","timestamp":1562716800000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"International Center for Medical Training and Research"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Brazilian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.bjid.2019.06.010","type":"journal-article","created":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T17:00:57Z","timestamp":1563814857000},"page":"237-245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinical and economic impact of generic versus brand name meropenem use in an intensive care unit in Colombia"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3879-3291","authenticated-orcid":false,"given":"Karen","family":"Ord\u00f3\u00f1ez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4436-1679","authenticated-orcid":false,"given":"Max M.","family":"Feinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7126-376X","authenticated-orcid":false,"given":"Sergio","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7633-6155","authenticated-orcid":false,"given":"Cristhian","family":"Hern\u00e1ndez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6093-7845","authenticated-orcid":false,"given":"Christian","family":"Pallares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1898-9067","authenticated-orcid":false,"given":"Mar\u00eda V.","family":"Villegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjid.2019.06.010_bib0005","unstructured":"U.S. Food And Drug Administration Code of Federal Regulations Title 21."},{"issue":"4","key":"10.1016\/j.bjid.2019.06.010_bib0010","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10156-012-0437-0","article-title":"Generic antibiotics in Japan","volume":"18","author":"Fujimura","year":"2012","journal-title":"J Infect Chemother"},{"issue":"4","key":"10.1016\/j.bjid.2019.06.010_bib0015","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.medmal.2011.10.013","article-title":"Generic antibiotic drugs: is effectiveness guaranteed?","volume":"42","author":"Gauzit","year":"2012","journal-title":"Med Mal Infect"},{"issue":"20","key":"10.1016\/j.bjid.2019.06.010_bib0020","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMp078193","article-title":"The ongoing regulation of generic drugs","volume":"357","author":"Frank","year":"2007","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.bjid.2019.06.010_bib0025","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2125.2010.03718.x","article-title":"Generic and therapeutic substitutions in the UK: are they a good thing?","volume":"70","author":"Duerden","year":"2010","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.bjid.2019.06.010_bib0030","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jinf.2007.09.011","article-title":"Incidence of postoperative infections in patients undergoing coronary artery bypass grafting surgery receiving antimicrobial prophylaxis with original and generic cefuroxime","volume":"56","author":"Mastoraki","year":"2008","journal-title":"J Infect"},{"issue":"8","key":"10.1016\/j.bjid.2019.06.010_bib0035","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1128\/AAC.01044-09","article-title":"Generic vancomycin products fail in vivo despite being pharmaceutical equivalents of the innovator","volume":"54","author":"Vesga","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.bjid.2019.06.010_bib0040","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1128\/AAC.05129-11","article-title":"Generic vancomycin enriches resistant subpopulations of Staphylococcus aureus after exposure in a neutropenic mouse thigh infection model","volume":"56","author":"Rodriguez","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.bjid.2019.06.010_bib0045","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1128\/AAC.00350-13","article-title":"Even apparently insignificant chemical deviations among bioequivalent generic antibiotics can lead to therapeutic nonequivalence: the case of meropenem","volume":"58","author":"Agudelo","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.bjid.2019.06.010_bib0050","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/jac\/dkr134","article-title":"Economic incentives for the (over-)prescription of broad-spectrum antimicrobials in German ambulatory care","volume":"66","author":"Kaier","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.bjid.2019.06.010_bib0055","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/jac\/dkq093","article-title":"Effect of generics on price and consumption of ciprofloxacin in primary healthcare: the relationship to increasing resistance","volume":"65","author":"Jensen","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bjid.2019.06.010_bib0060","unstructured":"WHO Collaborating Center for Drug Statistics Methodology: Definition and general considerations."},{"key":"10.1016\/j.bjid.2019.06.010_bib0065","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ajic.2004.10.001","article-title":"National Nosocomial Infections Surveillance, Public Health Service, System Report data summary from January 1992 through June 2004, issued October 2004","volume":"32","author":"National Center for Infectious Diseases, Centers for Disease Control and Prevention, Division of Healthcare Quality Promotion, Public Health Service, US Department of Health and Human Services","year":"2004","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.bjid.2019.06.010_bib0070","article-title":"Relaci\u00f3n entre el consumo de antibi\u00f3ticos y la resistencia bacteriana en Bogot\u00e1","author":"Gutierrez","year":"2009","journal-title":"Univ Nac Colomb"},{"key":"10.1016\/j.bjid.2019.06.010_bib0075","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2165\/00003495-200868060-00006","article-title":"Meropenem: a review of its use in the treatment of serious bacterial infections","volume":"68","author":"Baldwin","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.bjid.2019.06.010_bib0080","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jclinepi.2005.06.004","article-title":"A Colombian survey found intensive care mortality ratios were better in private vs. public hospitals","volume":"59","author":"P\u00e9rez","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.bjid.2019.06.010_bib0085","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0300-2896(02)75168-5","article-title":"Factors associated with hospital mortality in patients admitted to the intensive care unit in Colombia","volume":"38","author":"Dennis","year":"2002","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.bjid.2019.06.010_bib0090","first-page":"17","article-title":"Predicci\u00f3n de mortalidad en cuidado intensivo M\u00e9dicos, Apache II y MPM","volume":"21","author":"Dennis","year":"1996","journal-title":"Acta Med Colomb"},{"key":"10.1016\/j.bjid.2019.06.010_bib0095","first-page":"7","article-title":"Estudio descriptivo sobre la correlaci\u00f3n de veintise\u00eds variables demogr\u00e1ficas y fisiol\u00f3gicas con la mortalidad de una poblaci\u00f3n de pacientes en una unidad de cuidado intensivo en Colombia","volume":"35","author":"D\u00edaz","year":"1994","journal-title":"Univ Med"},{"key":"10.1016\/j.bjid.2019.06.010_bib0100","article-title":"Mortalidad e infecciones nosocomiales en dos unidades de cuidados intensivos de la ciudad de Barranquilla (Colombia)","volume":"24","author":"Dur\u00e1n P\u00e9rez","year":"2012","journal-title":"Rev Cient\u00edfica Salud Uninorte"},{"key":"10.1016\/j.bjid.2019.06.010_bib0105","doi-asserted-by":"crossref","first-page":"148","DOI":"10.7705\/biomedica.v34i0.1646","article-title":"Mortality risk factors associated with healthcare infections in a tertiary level university hospital in Colombia","volume":"34","author":"Pallares","year":"2014","journal-title":"Biomedica"},{"key":"10.1016\/j.bjid.2019.06.010_bib0110","series-title":"Colombia Digital Government\u2014SOAT Manual","year":"2017"},{"issue":"2","key":"10.1016\/j.bjid.2019.06.010_bib0115","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijantimicag.2014.10.014","article-title":"Relevance of various animal models of human infections to establish therapeutic equivalence of a generic product of piperacillin\/tazobactam","volume":"45","author":"Agudelo","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bjid.2019.06.010_bib0120","first-page":"S217","article-title":"Monitoring of effectiveness and safety of generic formulation of meropenem for treatment of infections at Siriraj Hospital","volume":"94","author":"Angkasekwinai","year":"2011","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.bjid.2019.06.010_bib0125","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/cid\/cit769","article-title":"Efficacy and quality of antibacterial generic products approved for human use: a systematic review","volume":"58","author":"Tattevin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2019.06.010_bib0130","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1128\/AAC.03710-14","article-title":"Pharmacodynamic evaluation of the activities of six parenteral vancomycin products available in the United States","volume":"59","author":"Louie","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2019.06.010_bib0135","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1128\/AAC.00164-12","article-title":"Quality assessment of U.S. marketplace vancomycin for injection products using high-resolution liquid chromatography-mass spectrometry and potency assays","volume":"56","author":"Hadwiger","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2019.06.010_bib0140","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.diagmicrobio.2014.04.007","article-title":"How severe is antibiotic pharmacokinetic variability in critically ill patients and what can be done about it?","volume":"79","author":"Felton","year":"2014","journal-title":"Diagn Microbiol Infect Dis [Internet]"}],"container-title":["The Brazilian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867019301680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867019301680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:54:26Z","timestamp":1761407666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1413867019301680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1413867019301680"],"URL":"https:\/\/doi.org\/10.1016\/j.bjid.2019.06.010","relation":{},"ISSN":["1413-8670"],"issn-type":[{"value":"1413-8670","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and economic impact of generic versus brand name meropenem use in an intensive care unit in Colombia","name":"articletitle","label":"Article Title"},{"value":"The Brazilian Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjid.2019.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Sociedade Brasileira de Infectologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}